{"nctId":"NCT03383783","briefTitle":"Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model","startDateStruct":{"date":"2017-12-19","type":"ACTUAL"},"conditions":["Caries"],"count":28,"armGroups":[{"label":"Treatment Period 1","type":"OTHER","interventionNames":["Drug: 0 ppm F (placebo, negative control)","Drug: 250 ppm F as NaF (dose-response control)","Drug: 500 ppm F as NaF (dose-response control)","Drug: 1100 ppm F as NaF (positive control)"]},{"label":"Treatment Period 2","type":"OTHER","interventionNames":["Drug: 0 ppm F (placebo, negative control)","Drug: 250 ppm F as NaF (dose-response control)","Drug: 500 ppm F as NaF (dose-response control)","Drug: 1100 ppm F as NaF (positive control)"]},{"label":"Treatment Period 3","type":"OTHER","interventionNames":["Drug: 0 ppm F (placebo, negative control)","Drug: 250 ppm F as NaF (dose-response control)","Drug: 500 ppm F as NaF (dose-response control)","Drug: 1100 ppm F as NaF (positive control)"]},{"label":"Treatment Period 4","type":"OTHER","interventionNames":["Drug: 0 ppm F (placebo, negative control)","Drug: 250 ppm F as NaF (dose-response control)","Drug: 500 ppm F as NaF (dose-response control)","Drug: 1100 ppm F as NaF (positive control)"]}],"interventions":[{"name":"0 ppm F (placebo, negative control)","otherNames":["Sensodyne sodium fluoride/silica toothpaste base formulation"]},{"name":"250 ppm F as NaF (dose-response control)","otherNames":["Sensodyne sodium fluoride/silica toothpaste base formulation"]},{"name":"500 ppm F as NaF (dose-response control)","otherNames":["Sensodyne sodium fluoride/silica toothpaste base formulation"]},{"name":"1100 ppm F as NaF (positive control)","otherNames":["Sensodyne sodium fluoride/silica toothpaste base formulation"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. provide voluntary, written informed consent;\n2. be between 18 and 85 years old;\n3. understand and be willing, able and likely to comply with all study procedures and restrictions;\n4. be wearing a removable mandibular partial denture with sufficient room in one posterior buccal flange area to accommodate two enamel specimens (required dimensions 12 × 7 mm) and room on the same side to accommodate two 4 mm round specimens in the buccal surface of two posterior denture teeth;\n5. be willing and capable of wearing their removable partial denture 24 hours a day for four (4), two-week treatment periods;\n6. be willing to allow study personnel to drill specimen sites (as described #4) in their mandibular partial denture;\n7. be in good medical and dental health with no active caries or periodontal disease; NOTE; subjects presenting at screening with caries may continue in the study if their carious lesions are restored prior to beginning treatment 1.\n8. have a salivary flow rate in the range of normal values (unstimulated whole saliva flow rate ≥ 0.2 mL/min; gum base stimulated whole saliva flow rate ≥ 0.8 mL/min).\n\nExclusion Criteria:\n\n1. currently be pregnant, intending to become pregnant during the study period or breast feeding;\n2. currently have any medical condition that could be expected to interfere with the subject's safety during the study period;\n3. currently be taking antibiotics or have taken antibiotics in the two weeks prior to the beginning treatment 1;\n4. have participated in another clinical study or receipt of an investigational drug within 30 days of beginning treatment 1; or\n5. be taking fluoride supplements, required to use a fluoride mouthrinse or have received a professional fluoride treatment in the two weeks preceding specimen placement;\n6. be taking or have ever taken bisphosphonate drugs (e.g., Fosamax, Actonel and Boniva) for the treatment of osteoporosis;","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage Surface Microhardness Recovery (%SMH)","description":"The extent of remineralization will be calculated based on the method of \\[Gelhard et al., 1979\\].\n\n* SMH recovery = (D1-R)/(D1-B) ×100 B = indentation length (µm) of sound enamel specimen at baseline D1 = indentation length (µm) after in vitro demineralization R = indentation length (µm) after intra-oral exposure.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.96","spread":null},{"groupId":"OG001","value":"30.59","spread":null},{"groupId":"OG002","value":"40.74","spread":null},{"groupId":"OG003","value":"48.28","spread":null},{"groupId":"OG004","value":"7.42","spread":null},{"groupId":"OG005","value":"16.27","spread":null},{"groupId":"OG006","value":"21.59","spread":null},{"groupId":"OG007","value":"26.75","spread":null}]}]}]},{"type":"SECONDARY","title":"Net Acid Resistance (NAR)","description":"The %NAR will be calculated by the method of Corpron \\[Corpron et al., 1986\\]:\n\n* Net Acid Resistance = \\[(D1-D2) / (D1-B)\\] \\* 100 B= Indentation length (µm) of sound enamel at baseline D1= Indentation length (µm) after first in vitro demineralization D2= Indentation length (µm) after second in vitro demineralization","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-22.68","spread":null},{"groupId":"OG001","value":"11.43","spread":null},{"groupId":"OG002","value":"18.66","spread":null},{"groupId":"OG003","value":"31.79","spread":null},{"groupId":"OG004","value":"-18.60","spread":null},{"groupId":"OG005","value":"1.99","spread":null},{"groupId":"OG006","value":"8.31","spread":null},{"groupId":"OG007","value":"16.87","spread":null}]}]}]},{"type":"SECONDARY","title":"Comparative Acid Resistance (CAR)","description":"Using the data from the four centrally located enamel specimens, the equation used will compare explicitly the reduction in SMH brought by the first and second acid challenges:\n\n* Comparative Acid Resistance = \\[(D2-R) / (D1-B)\\] \\* 100 B= Indentation length (µm) of sound enamel at baseline R= Indentation length (µm) of enamel after in situ remineralization D1= Indentation length (µm) after first in vitro demineralization D2= Indentation length (µm) after second in vitro demineralization","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36.42","spread":null},{"groupId":"OG001","value":"19.20","spread":null},{"groupId":"OG002","value":"22.16","spread":null},{"groupId":"OG003","value":"16.27","spread":null},{"groupId":"OG004","value":"25.82","spread":null},{"groupId":"OG005","value":"14.31","spread":null},{"groupId":"OG006","value":"13.33","spread":null},{"groupId":"OG007","value":"9.71","spread":null}]}]}]},{"type":"SECONDARY","title":"Enamel Fluoride Uptake (EFU)","description":"The amount of fluoride-uptake by enamel will be calculated based on the amount of fluoride divided by the area of the enamel cores and expressed as µg F/cm2.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.96","spread":null},{"groupId":"OG001","value":"2.25","spread":null},{"groupId":"OG002","value":"2.69","spread":null},{"groupId":"OG003","value":"2.98","spread":null},{"groupId":"OG004","value":"0.96","spread":null},{"groupId":"OG005","value":"2.14","spread":null},{"groupId":"OG006","value":"2.50","spread":null},{"groupId":"OG007","value":"2.73","spread":null}]}]}]},{"type":"SECONDARY","title":"Transverse Microradiography (TMR) - Integrated Mineral Loss - ∆Z","description":"Lesions will be analyzed after in situ demineralization and the following three parameters calculated:\n\n1. Integrated Mineral Loss - ∆Z= \\[(lesion depth x 87) - area under the curve\\*\\]\n2. Lesion Depth - L (83% mineral i.e. 95% of the mineral content of sound enamel)\n3. Maximum mineral density at the surface-zone - SZmax","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1240","spread":null},{"groupId":"OG001","value":"902","spread":null},{"groupId":"OG002","value":"664","spread":null},{"groupId":"OG003","value":"684","spread":null},{"groupId":"OG004","value":"1526","spread":null},{"groupId":"OG005","value":"912","spread":null},{"groupId":"OG006","value":"901","spread":null},{"groupId":"OG007","value":"859","spread":null}]}]}]},{"type":"SECONDARY","title":"Transverse Microradiography (TMR) - Lesion Depth - L","description":"Lesions will be analyzed after in situ demineralization and the following three parameters calculated:\n\n1. Integrated Mineral Loss - ∆Z= \\[(lesion depth x 87) - area under the curve\\*\\]\n2. Lesion Depth - L (83% mineral i.e. 95% of the mineral content of sound enamel)\n3. Maximum mineral density at the surface-zone - SZmax","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52.01","spread":null},{"groupId":"OG001","value":"41.74","spread":null},{"groupId":"OG002","value":"34.85","spread":null},{"groupId":"OG003","value":"27.31","spread":null},{"groupId":"OG004","value":"60.73","spread":null},{"groupId":"OG005","value":"42.12","spread":null},{"groupId":"OG006","value":"37.38","spread":null},{"groupId":"OG007","value":"36.02","spread":null}]}]}]},{"type":"SECONDARY","title":"Transverse Microradiography (TMR) - Maximum Mineral Density at the Surface-zone","description":"Lesions will be analyzed after in situ demineralization and the following three parameters calculated:\n\n1. Integrated Mineral Loss - ∆Z= \\[(lesion depth x 87) - area under the curve\\*\\]\n2. Lesion Depth - L (83% mineral i.e. 95% of the mineral content of sound enamel)\n3. Maximum mineral density at the surface-zone - SZmax (arbitrary unit from TMR software)","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"62.17","spread":null},{"groupId":"OG001","value":"62.54","spread":null},{"groupId":"OG002","value":"67.13","spread":null},{"groupId":"OG003","value":"65.93","spread":null},{"groupId":"OG004","value":"61.22","spread":null},{"groupId":"OG005","value":"62.99","spread":null},{"groupId":"OG006","value":"61.38","spread":null},{"groupId":"OG007","value":"63.66","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":27},"commonTop":["Mouth Erythema","Mouth Ulceration","Common Cold","Back Pain","Diarrhea"]}}}